The Valley Desk

NCT03566043 · Interventional trial

CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions Mucopolysaccharidosis Type II (MPS II)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov